Avidity Biosciences Announces Positive AOC 1001 Data In Myotonic Dystrophy Type 1
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Avidity Biosciences Inc. (RNA) announced new positive AOC 1001 data demonstrating improvement in multiple additional functional endpoints and favorable long-term safety and tolerability in people living with myotonic dystrophy type 1 or DM1.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-172202514-d0ed8243906e47208b08a376e0bcbdc7.jpg "Understanding a Quarterly Financial Report and Its Requirements")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1242296951-27b133dc7f934b55bf95e116f5878994.jpg "<div>Accumulated Depreciation vs. Depreciation Expense: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1949225438-f66c00f738e64306b7ae9ef74c7c6d53.jpg "4 Money Misconceptions About Condominiums")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1469139307-0965f4cd1c9245a8a05e4c641615d9ac.jpg "Risk Management Framework (RMF): Definition and Components")